Impact of adherence to a lifestyle-integrated programme on physical function and behavioural complexity in young older adults at risk of functional decline: a multicentre RCT secondary analysis. Issue 10 (5th October 2022)

• Record Type: Journal Article
• Authors: Mikolaizak, A Stefanie; Taraldsen, Kristin; Boulton, Elisabeth; Gordt, Katharina; Maier, Andrea Britta; Mellone, Sabato; Hawley-Hague, Helen; Aminian, Kamiar; Chiari, Lorenzo; Paraschiv-Ionescu, Anisoara; Pijnappels, Mirjam; Todd, Chris; Vereijken, Beatrix; Helbostad, Jorunn L; Becker, Clemens
• Is Part Of: BMJ open. Volume 12:Issue 10(2022)
• Publication Date: 2022-10-05
• Subjects: telemedicine -- geriatric medicine -- public health -- sports medicine; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2021-054229
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Context: Long-term adherence to physical activity (PA) interventions is challenging. The Lifestyle-integrated Functional Exercise programmes were adapted Lifestyle-integrated Functional Exercise (aLiFE) to include more challenging activities and a behavioural change framework, and then enhanced Lifestyle-integrated Functional Exercise (eLiFE) to be delivered using smartphones and smartwatches. Objectives: To (1) compare adherence measures, (2) identify determinants of adherence and (3) assess the impact on outcome measures of a lifestyle-integrated programme. Design, setting and participants: A multicentre, feasibility randomised controlled trial including participants aged 61–70 years conducted in three European cities. Interventions: Six-month trainer-supported aLiFE or eLiFE compared with a control group, which received written PA advice. Outcome measures: Self-reporting adherence per month using a single question and after 6-month intervention using the Exercise Adherence Rating Scale (EARS, score range 6–24). Treatment outcomes included function and disability scores (measured using the Late-Life Function and Disability Index) and sensor-derived physical behaviour complexity measure. Determinants of adherence (EARS score) were identified using linear multivariate analysis. Linear regression estimated the association of adherence on treatment outcome. Results: We included 120 participants randomised to the intervention groups (aLiFE/eLiFE) (66.3±2.3 years, 53% women). The 106 participants reassessed after 6 months had a mean EARS score of 16.0±5.1. Better adherence was associated with lower number of medications taken, lower depression and lower risk of functional decline. We estimated adherence to significantly increase basic lower extremity function by 1.3 points (p<0.0001), advanced lower extremity function by 1.0 point (p<0.0001) and behavioural complexity by 0.008 per 1.0 point higher EARS score (F(3, 91)=3.55, p=0.017) regardless of group allocation. Conclusion: PA adherence was associated with better lower extremity function and physical behavioural complexity. Barriers to adherence should be addressed preintervention to enhance intervention efficacy. Further research is needed to unravel the impact of behaviour change techniques embedded into technology-delivered activity interventions on adherence. Trial registration number: NCT03065088 .